Ota, Japan Clinical Trials

A listing of Ota, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 574 clinical trials
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Objectives in this study is to compare the change of lung function after 24 months from baseline between the two groups; one is the patient group who decided to start biologics treatment, and another is the patient group who decided to start non-biologics treatment. The target patients are the adult …

Research Site
 (3.4 away) Contact site
  • 12 Sep, 2021
  • +28 other locations
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

This study is a survey in Japan of Cabozantinib tablets used to treat people with a type of kidney cancer called renal cell carcinoma. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during …

Takeda selected site
 (8.9 away) Contact site
  • 30 Apr, 2021
  • 1 location
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa

The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RPGR) gene and to investigate their associated phenotype.

National Hospital Organization Tokyo Medical Center
 (5.3 away) Contact site
  • 22 Sep, 2021
  • 1 location
A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

This study is a prospective, uncontrolled, central registration system, multicenter, domestic observational study (special drug-use surveillance) to evaluate the safety of 52-week clinical treatment with Beovu kit for intravitreal injection in nAMD patients.

Novartis Investigative Site
 (7.7 away) Contact site
  • 24 Sep, 2021
  • +65 other locations